Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients.
about
Meta-analysis of the comparative effects of different classes of antihypertensive agents on brachial and central systolic blood pressure, and augmentation indexComparison of effects of azelnidipine and trichlormethiazide in combination with olmesartan on blood pressure and metabolic parameters in hypertensive type 2 diabetic patientsManagement of Hypertension Using Olmesartan Alone or in CombinationEfficacy and safety of a lercanidipine/enalapril fixed-dose combination in hypertensive patients in PortugalArterial stiffness and cardiovascular therapyCombinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: a randomized, controlled trial.Critical appraisal of the differential effects of antihypertensive agents on arterial stiffness.Combination therapy of hypertension in the elderly: a subgroup analysis of the Combination of OLMesartan and a calcium channel blocker or diuretic in Japanese elderly hypertensive patients trialOlmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS studyArterial stiffness and cognitive function in the elderly.Effects of Azelnidipine plus OlmesaRTAn versus amlodipine plus olmesartan on central blood pressure and left ventricular mass index: the AORTA study.Impact of Antihypertensive Agents on Central Systolic Blood Pressure and Augmentation Index: A Meta-Analysis.Preferable effects of olmesartan/calcium channel blocker to olmesartan/diuretic on blood pressure variability in very elderly hypertension: COLM study subanalysis.Key Points of the Japanese Society of Hypertension Guidelines for the Management of Hypertension in 2014Rationale, study design, baseline characteristics and blood pressure at 16 weeks in the HONEST Study.Brachial-ankle pulse wave velocity is the only index of arterial stiffness that correlates with a mitral valve indices of diastolic dysfunction, but no index correlates with left atrial size.Effects of Anti-Hypertensive Monotherapy with Either Calcium Channel Blocker or Angiotensin Receptor Blocker on Arterial Stiffness, Central Hemodynamics, and Ventriculo-Arterial Coupling in Uncomplicated Hypertension Patients.Azelnidipine plus olmesartan versus amlodipine plus olmesartan on arterial stiffness and cardiac function in hypertensive patients: a randomized trialPersistent olmesartan-based blood pressure-lowering effects on morning hypertension in Asians: the HONEST study.Different associations between beta-blockers and other antihypertensive medication combinations with brachial blood pressure and aortic waveform parameters.24-hour central aortic systolic pressure and 24-hour central pulse pressure are related to diabetic complications in type 1 diabetes - a cross-sectional study.Comparative effectiveness of a fixed-dose combination of losartan + HCTZ versus bisoprolol + HCTZ in patients with moderate-to-severe hypertension: results of the 6-month ELIZA trial.Comparable effect of aliskiren or a diuretic added on an angiotensin II receptor blocker on augmentation index in hypertension: a multicentre, prospective, randomised studyArterial stiffness, its assessment, prognostic value, and implications for treatment.Antihypertensive therapy and de-stiffening of the arteries.The Cardiovascular Continuum extended: aging effects on the aorta and microvasculature.Use of dihydropyridine calcium channel blockers in the management of hypertension in Eastern Asians: a scientific statement from the Asian Pacific Heart Association.The effect of amlodipine besylate, losartan potassium, olmesartan medoxomil, and other antihypertensives on central aortic blood pressure and biomarkers of vascular function.Angiotensin receptor blockers: pharmacology, efficacy, and safety.Arterial aging: a review of the pathophysiology and potential for pharmacological intervention.Noninvasive studies of central aortic pressure.Arterial stiffness as a cause of cognitive decline and dementia: a systematic review and meta-analysis.Emerging concept of anti-hypertensive therapy based on ambulatory blood pressure profile in chronic kidney disease.Role of antihypertensive drugs in arterial 'de-stiffening' and central pulsatile hemodynamics.Diuretics in the treatment of hypertension. Part 1: thiazide and thiazide-like diuretics.How should we manage a patient with masked hypertension?De-stiffening drug therapy and blood pressure control.Perfect 24-h management of hypertension: clinical relevance and perspectives.Differential Effects in Cardiovascular Markers between High-Dose Angiotensin II Receptor Blocker Monotherapy and Combination Therapy of ARB with Calcium Channel Blocker in Hypertension (DEAR Trial).Urinary albumin excretion during angiotensin II receptor blockade: comparison of combination treatment with a diuretic or a calcium-channel blocker.
P2860
Q26861653-45AC0224-9248-4CE4-A4BA-AEF020DB4A9AQ33585594-FEDD7872-EFB9-4784-A32D-D6FDCB5AE4CFQ33734043-211887A8-90A0-400B-83FC-00870D942EDFQ33804767-5B6D1498-89F3-4D7F-94B6-027A50899160Q34079790-F76BCD7F-3BF0-4D74-BDD0-C851295B9648Q34196851-BFCB10E5-B462-4DF3-A41E-60B01064F244Q34632600-00EB0A98-84B3-4A20-97BB-13AA5696FB08Q34876994-199EFA5C-29AA-4CCC-8F94-EC145C49E9E2Q34995916-DE948FD5-7BA7-4D82-93CE-FED2845B6EBDQ35037083-7AD14FDE-C686-40A8-9E9D-4D2588C1D45BQ35122929-E67CB24B-AE1E-4F33-B3B2-193A571F93FAQ35750717-4944F924-9806-4FEA-B230-436BBF7BA17FQ36061968-6BEC8B26-3532-4A59-9F88-D66060ED8950Q36283161-44254067-1EB6-4E74-A842-540C09E03EBDQ36589337-722A65E5-74E3-4CE8-8BBC-4D0F25807122Q36711621-12C5A6F3-FA71-4DFC-BAA1-2AB5ADD77074Q36721700-A83D20D4-5163-4A2D-8DFB-10770754534DQ36723396-E135F1D1-B69B-47CA-9CBC-B6FB5D5B656DQ36896791-5921EAD9-9791-4B34-A4AA-C685D26FFF0EQ37135698-6A60A554-657E-4233-8299-8833DC43D219Q37153153-BD529F4E-E5AF-407C-87FC-5DADC4B54934Q37221225-81077DDB-468A-4FC5-ADF1-94E83AF2E2B0Q37741709-2337E5B3-E3B4-4142-B32D-2042B92A16AEQ37799720-EA71D8AF-A54A-4937-93AF-FD37ED399008Q37803234-FB9F1983-12E9-44C2-A59C-8608AE1133ABQ37807824-977F22FB-F045-468C-9C84-9ED613C9958BQ37828060-6D5AEBE3-026B-4A22-8549-AF5754268DC1Q37926767-23C5ECB1-7809-4636-B129-0A1F72A79FEBQ37928133-4EF27FD7-39D2-4AC3-809F-EF07BED098FFQ37942220-FCF28108-3656-4FD8-A385-1A78B01DF42AQ37956134-EFD780BB-3DC0-4246-8293-0E64136DCC55Q37965883-E7D9FF61-45C7-46EB-8E79-EA8187214695Q37976710-1B881B4A-DD7B-4219-9773-5FA1CC1EC07DQ38006018-CF2F938F-4A33-4319-B273-CECC0616AA80Q38180204-F0BDF7BD-620F-4FFB-84D7-87BF40926BDAQ38185610-589DC1BE-5831-4709-AF4D-D22A912B4BF5Q38390996-F35D5741-9938-4B06-84D9-DF3A4CA8871DQ38823545-50D9A229-3B45-41FF-B82A-B601F33AED82Q39729039-08663E49-28B4-4E1D-9279-AAC37216386EQ42683387-21DF0096-BF65-4888-834A-7095B3C1A27E
P2860
Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Differential effects between a ...... sure in hypertensive patients.
@en
Differential effects between a ...... sure in hypertensive patients.
@nl
type
label
Differential effects between a ...... sure in hypertensive patients.
@en
Differential effects between a ...... sure in hypertensive patients.
@nl
prefLabel
Differential effects between a ...... sure in hypertensive patients.
@en
Differential effects between a ...... sure in hypertensive patients.
@nl
P2093
P1433
P1476
Differential effects between a ...... sure in hypertensive patients.
@en
P2093
Hiroshi Miyashita
Joji Ishikawa
Kazuomi Kario
Kazuyuki Shimada
Michael F O'Rourke
Yoshio Matsui
P304
P356
10.1161/HYPERTENSIONAHA.109.131466
P407
P50
P577
2009-08-10T00:00:00Z